Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection

Strati Paolo; Nastoupil Loretta J.; Fayad Luis E.; Samaniego Felipe; Adkins Sherry; Neelapu Sattva S.

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection

【24h】

Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection

机译：B细胞淋巴瘤患者的汽车T细胞治疗安全性和慢性乙型肝炎或C病毒感染

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2019年第26期|共3页
作者
Strati Paolo; Nastoupil Loretta J.; Fayad Luis E.; Samaniego Felipe; Adkins Sherry; Neelapu Sattva S.;
展开▼
作者单位

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

Univ Texas MD Anderson Canc Ctr Dept Lymphoma &

Myeloma Houston TX 77030 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. 中国南方单中心622例成熟T细胞和自然杀伤细胞淋巴瘤患者中CD30在结外鼻型自然杀伤/T细胞淋巴瘤组织中的表达 [J] . Yanfen Feng, Huilan Rao, Yiyan Lei, 癌症（英文版） . 2018,第005期
2. Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection [J] . Strati Paolo, Nastoupil Loretta J., Fayad Luis E., Blood: The Journal of the American Society of Hematology . 2019,第26期

机译：B细胞淋巴瘤患者的汽车T细胞治疗安全性和慢性乙型肝炎或C病毒感染
3. Feasibility and safety of concomitant antiviral therapy with DAAs and chemotherapy in patients with HCV chronic hepatitis and aggressive B-cell non-Hodgkin lymphomas [J] . Labanca Sara, Capecchi Marco, Occhipinti Vincenzo, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：HCV慢性肝炎患者伴随抗病毒治疗的可行性和安全性和化疗，慢性肝炎患者和侵袭性B细胞非霍奇金淋巴瘤
4. Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy [J] . Totani Haruhito, Kusumoto Shigeru, Ishida Takashi, International journal of hematology . 2015,第4期

机译：成人T细胞白血病-淋巴瘤患者经全身化疗后已解决的HBV感染的再激活乙肝病毒（HBV）感染
5. Dynamics of a Chronic Hepatitis B Virus Infection Model with Drug Therapy and Immune Responses [C] . Jianhua Pang, Jing-an Cui, Jing Hui International congress on mathematical biology;ICMB2011 . 2011

机译：具有药物治疗和免疫反应的慢性乙型肝炎病毒感染模型的动力学。
6. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
7. Hemorrhagic Cystitis Secondary to Adenovirus and BK Virus Infection in a Diffuse Large B-Cell Lymphoma Patient with Recent CAR T-Cell Therapy [O] . Abdul Moiz Khan, Zainub Ajmal, Fatima Tuz Zahra, 2020

机译：具有最近的汽车T细胞疗法的弥漫性大B细胞淋巴瘤患者中患腺病毒和BK病毒感染的出血性膀胱炎
8. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti- hepatitis C virus?positive blood donors without viremi [O] . M Lechmann, H G Ihlenfeldt, I Braunschweiger, 1996

机译：对慢性丙型肝炎感染患者和健康抗丙型肝炎病毒的不同丙型肝炎病毒抗原的T-和B细胞反应？没有viremi的正血液供体

Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection

著录项

引文网络

相似文献

相关主题

期刊订阅